Spots Global Cancer Trial Database for Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Official Title: A Phase 2, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Patients With Locally Advanced Unresectable or Metastatic Esophageal Squamous Cell Carcinoma That Progressed on or After Anti-PD-(L)1 Antibody Therapy
Study ID: NCT05461794
Conditions
Study Description
Brief Summary: The purpose of this study is to investigate the efficacy and safety of sitravatinib in combination with tislelizumab for the treatment of participants with esophageal squamous cell carcinoma
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Anhui Provincial Hospital South Brance, Hefei, Anhui, China
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei, Anhui, China
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Beijing Cancer Hospital, Beijing, Beijing, China
Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing, China
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Sun Yat Sen University Cancer Center, Guangzhou, Guangdong, China
Sun Yat Sen University Cancer Center(Huangpu Campus), Guangzhou, Guangdong, China
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China
The Tumor Hospital Affiliated to Guangxi Medical University, Nanning, Guangxi, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Xiangyang Central Hospital, Xiangyang, Hubei, China
Northern Jiangsu Peoples Hospital, Yangzhou, Jiangsu, China
Ganzhou Peoples Hospital Ganzhou Hospital Affiliated to Nanchang University, Ganzhou, Jiangxi, China
Jilin Cancer Hospital, Changchun, Jilin, China
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
Shandong Cancer Hospital, Jinan, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu, Sichuan, China
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
